Inhibitory Effects of Total Triterpenoid Saponins Isolated from the Seeds of the Tea Plant (Camellia sinensis) on Human Ovarian Cancer Cells

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer

(2016) E. M. V. de Cuba et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Theaflavin-3, 3′-digallate induces apoptosis and G2 cell cycle arrest through the Akt/MDM2/p53 pathway in cisplatin-resistant ovarian cancer A2780/CP70 cells

(2016) YOUYING TU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

20(S)-Protopanaxadiol saponins inhibit SKOV3 cell migration

(2016) BIN LI et al.   Oncology Letters

Expression of Interactive Genes Associated with Apoptosis and Their Prognostic Value for Ovarian Serous Adenocarcinoma

(2016) Heungyeol Kim et al.   Advances in Clinical and Experimental Medicine

Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant ovarian cancer cells

(2015) Bo Li et al.   CANCER LETTERS

PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples

(2015) Boris Winterhoff et al.   EUROPEAN JOURNAL OF CANCER

Theaflavin-3, 3′-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways

(2015) YING GAO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

In vitro Antifungal Activity and Mechanism of Action of Tea Polyphenols and Tea Saponin against Rhizopus stolonifer

(2015) Xiaodong Jiang et al.   JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY

Paris saponin II inhibits human ovarian cancer cell-induced angiogenesis by modulating NF-κB signaling

(2015) MEI YANG et al.   ONCOLOGY REPORTS

Cancer chemopreventive theasaponin derivatives from the total tea seed saponin of Camellia sinensis

(2015) Weihong Zhao et al.   Journal of Functional Foods

Medicinal Flowers. XXXIII. Anti-hyperlipidemic and Anti-hyperglycemic Effects of Chakasaponins I–III and Structure of Chakasaponin IV from Flower Buds of Chinese Tea Plant (Camellia sinensis)

(2015) Hisashi Matsuda et al.   CHEMICAL & PHARMACEUTICAL BULLETIN

Theasaponin E1as an effective ingredient for anti-angiogenesis and anti-obesity effects

(2014) Jong-Deog Kim et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration

(2014) Xue Xiao et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Immunomodulatory effect of tea saponin in immune T-cells and T-lymphoma cellsviaregulation of Th1, Th2 immune response and MAPK/ERK2 signaling pathway

(2014) Jyoti Bhardwaj et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Ginsenoside 20(S)-Rg3 inhibits the Warburg effect through STAT3 pathways in ovarian cancer cells

(2014) JIE LI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

21-O-Angeloyltheasapogenol E3, a Novel Triterpenoid Saponin from the Seeds of Tea Plants, Inhibits Macrophage-Mediated Inflammatory Responses in a NF-κB-Dependent Manner

(2014) Woo Seok Yang et al.   MEDIATORS OF INFLAMMATION

Epigallocatechin-3-gallate inhibits the proliferation and migration of human ovarian carcinoma cells by modulating p38 kinase and matrix metalloproteinase-2

(2014) FENG WANG et al.   Molecular Medicine Reports

Ginsenoside 20(S)-Rg3 Targets HIF-1α to Block Hypoxia-Induced Epithelial-Mesenchymal Transition in Ovarian Cancer Cells

(2014) Ting Liu et al.   PLoS One

The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis

(2014) W Ren et al.   SWISS MEDICAL WEEKLY

20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways

(2014) Jia-He Wang et al.   TUMOR BIOLOGY

Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer

(2013) Shailendra Giri et al.   PLoS One

On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy

(2012) Santiago Gómez-Ruiz et al.   BIOINORGANIC CHEMISTRY AND APPLICATIONS

Phytochemical analysis of the triterpenoids with cytotoxicity and QR inducing properties from the total tea seed saponin of Camellia sinensis

(2012) Ning Li et al.   FITOTERAPIA

In vitro cytotoxicity, antimicrobial, and metal-chelating activity of triterpene saponins from tea seed grown in Kangra valley, India

(2012) Robin Joshi et al.   MEDICINAL CHEMISTRY RESEARCH

Ten-Year Relative Survival for Epithelial Ovarian Cancer

(2012) Lauren A. Baldwin et al.   OBSTETRICS AND GYNECOLOGY

Paris Saponin II of Rhizoma Paridis – A novel inducer of apoptosis in human ovarian cancer cells

(2012) Xue Xiao   BioScience Trends

Overview of anti-angiogenic agents in development for ovarian cancer

(2011) Robert A. Burger   GYNECOLOGIC ONCOLOGY

Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species

(2011) Yeong-In Yang et al.   GYNECOLOGIC ONCOLOGY

Apoptosis in cancer: from pathogenesis to treatment

(2011) Rebecca SY Wong   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The function of vascular endothelial growth factor

(2009) Bonnie J. Nieves et al.   BIOFACTORS

Control of mitochondrial apoptosis by the Bcl-2 family

(2009) J. K. Brunelle et al.   JOURNAL OF CELL SCIENCE

The Future of Targeted Therapies in Ovarian Cancer

(2009) S. Banerjee et al.   ONCOLOGIST

Surgical Management of Recurrent Ovarian Cancer

(2009) Mario M. Leitao et al.   SEMINARS IN ONCOLOGY

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells

(2008) Travis W. Day et al.   BIOCHEMICAL PHARMACOLOGY

Reactive oxygen species and HIF-1 signalling in cancer

(2008) Alex Galanis et al.   CANCER LETTERS